NCT07161908
Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved at least 4 months later.
See at-risk trials from Institute of Health Information and Statistics of the Czech Republic
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 9 words
- Primary completion pushed from Nov 2026 to Apr 2027
- Study completion pushed from Feb 2027 to Aug 2027
- Study description revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Average duration of controlled oxygen therapy in a premature infant
Timeframe: From the enrollment to 4 weeks after discontinuation of home oxygen therapy application in child (complete weaning from oxygen supply)
Secondary (1)
Average number of failures in premature infants before the termination of controlled oxygen therapy
Arms and interventions
Controlled remote oxygen therapyExperimental
The patients will be following study protocol of optimization of oxygen therapy.
Devices: Pulse oximeter
Sites
4 sites in 1 country